Rhabdomyolysis susceptibility 1 (RHABDO1) is an autosomal recessive predisposition to recurrent, often severe rhabdomyolysis caused by biallelic loss-of-function variants in OBSCN. OBSCN encodes obscurin, a giant sarcomeric scaffold protein that binds titin and myomesin at the M-band and, through its C-terminus, the sarcoplasmic reticulum anchor small ankyrin-1 (sAnk1.5) and ankyrin-B. Patients are usually well between attacks. Episodes begin in childhood or adolescence and are set off mainly by high-intensity exercise, sometimes by fever. They bring myalgia, cramps, very high serum creatine kinase, myoglobinuria and, in some cases, acute kidney injury. Patient muscle has little or no obscurin, and patient myoblasts lose more sarcoplasmic reticulum calcium under metabolic stress than control cells. Obscurin-knockout mice have a disorganized longitudinal sarcoplasmic reticulum, mislocalized ankyrin-B and dystrophin, a fragile sarcolemma, and exercise-induced muscle damage. No affected patient has had cardiomyopathy, although OBSCN variants have been reported in inherited cardiomyopathies. Penetrance is incomplete: a sibling carrying the same biallelic variants can remain free of rhabdomyolysis.
Ask a research question about Rhabdomyolysis Susceptibility To 1. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Rhabdomyolysis Susceptibility To 1
creation_date: "2026-10-27T18:02:59Z"
category: Mendelian
synonyms:
- RHABDO1
- OBSCN-related rhabdomyolysis
- OBSCN-related exercise intolerance
description: >-
Rhabdomyolysis susceptibility 1 (RHABDO1) is an autosomal recessive
predisposition to recurrent, often severe rhabdomyolysis caused by biallelic
loss-of-function variants in OBSCN. OBSCN encodes obscurin, a giant
sarcomeric scaffold protein that binds titin and myomesin at the M-band and,
through its C-terminus, the sarcoplasmic reticulum anchor small ankyrin-1
(sAnk1.5) and ankyrin-B. Patients are usually well between attacks. Episodes
begin in childhood or adolescence and are set off mainly by high-intensity
exercise, sometimes by fever. They bring myalgia, cramps, very high serum
creatine kinase, myoglobinuria and, in some cases, acute kidney injury.
Patient muscle has little or no obscurin, and patient myoblasts lose more
sarcoplasmic reticulum calcium under metabolic stress than control cells.
Obscurin-knockout mice have a disorganized longitudinal sarcoplasmic
reticulum, mislocalized ankyrin-B and dystrophin, a fragile sarcolemma, and
exercise-induced muscle damage. No affected patient has had cardiomyopathy,
although OBSCN variants have been reported in inherited cardiomyopathies.
Penetrance is incomplete: a sibling carrying the same biallelic variants
can remain free of rhabdomyolysis.
disease_term:
preferred_term: rhabdomyolysis, susceptibility to, 1
term:
id: MONDO:0859371
label: rhabdomyolysis, susceptibility to, 1
parents:
- Rhabdomyolysis
- Metabolic and Structural Myopathy
notes: >-
Scope: biallelic OBSCN loss of function predisposing to rhabdomyolysis,
matching MONDO:0859371 (OMIM:620235). The human evidence is a small number
of probands: six in the founding series (PMID:34957489), two in
PMID:38159459, and single cases in PMID:40186404, PMID:40813169 and
PMID:41645489. PMID:40186404 counts nine patients and fourteen variants
reported to that date. The mechanism nodes on sarcoplasmic reticulum
architecture and sarcolemmal fragility rest on obscurin-knockout mice; the
human evidence for them is reduced sarcoplasmic reticulum calcium content in
patient myoblasts and the proteomic and ultrastructural findings in one
biopsy (PMID:41645489). Heterozygous OBSCN variants, mostly missense, are
reported in hypertrophic and dilated cardiomyopathy and left ventricular
noncompaction. That is a different, mainly dominant and contested
association, and it is not recorded here. No GeneReviews chapter and no
prevalence figure were found.
inheritance:
- name: Autosomal recessive inheritance
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
description: >-
Affected individuals carry biallelic (homozygous or compound
heterozygous) loss-of-function OBSCN variants. Penetrance is incomplete:
rhabdomyolysis also needs an environmental trigger, and a sibling with
the same genotype has been reported without it.
evidence:
- reference: PMID:34957489
reference_title: "Bi-allelic loss-of-function OBSCN variants predispose individuals to severe recurrent rhabdomyolysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We identified 10 bi-allelic loss-of-function variants in the gene
encoding obscurin (OBSCN) predisposing individuals to recurrent
rhabdomyolysis.
explanation: >-
Disease alleles are biallelic in every proband of the founding series.
- reference: PMID:41645489
reference_title: "Myopathy With Exercise-Induced Intolerance due to Novel Biallelic Variants in OBSCN-A Clinical, Morphological and Molecular Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: BACKGROUND
snippet: >-
Interestingly, a sibling with the same biallelic OBSCN variants has not
presented with rhabdomyolysis.
explanation: >-
Records incomplete penetrance in a previously reported family. The
sentence restates an earlier report rather than this paper's own
patient.
genetic:
- name: OBSCN
gene_term:
preferred_term: OBSCN
term:
id: hgnc:15719
label: OBSCN
association: Causal
relationship_type: CAUSATIVE
notes: >-
Reported alleles are mostly nonsense, frameshift and splice variants. The
founding series describes 10 variants in six patients (PMID:34957489).
Missense alleles have been reported only in trans with a null allele
(PMID:41645489, p.Ala4864Asp, classified there as a VUS). OBSCN
missense variants are hard to interpret: the cardiomyopathy-associated
p.Arg4344Gln is carried by 15% of African Americans and did not change
titin binding or domain stability in vitro (PMID:33438037). No ClinGen
gene-disease validity assertion for OBSCN and rhabdomyolysis was found in
the local cache, so no validity tier is recorded.
evidence:
- reference: PMID:34957489
reference_title: "Bi-allelic loss-of-function OBSCN variants predispose individuals to severe recurrent rhabdomyolysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We show reduced expression of OBSCN and loss of obscurin protein in
patient muscle.
explanation: >-
The patient alleles abolish obscurin in skeletal muscle, consistent
with loss of function.
- reference: PMID:38159459
reference_title: "Novel OBSCN variants associated with a risk to exercise-intolerance and rhabdomyolysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Here we reported two young patients with a history of cramps, myalgia,
exercise intolerance, rhabdomyolysis, and myoglobinuria without any
evidence of concomitant cardiomyopathy in association with novel OBSCN
variants (c.24822C>A and c.2653+1G>C).
explanation: >-
An independent report of two further patients with OBSCN variants and
the same phenotype.
- reference: PMID:40186404
reference_title: "Identification of Compound Heterozygous Variants in OBSCN Gene Associated With Rhabdomyolysis: A Case Report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The patient carried compound heterozygous variants, including
c.21184C>T (nonsense variant) and c.15610+12C>T (intronic splicing
variant).
explanation: >-
A further compound heterozygous case, from China.
- reference: PMID:40813169
reference_title: "Rhabdomyolysis associated with OBSCN mutations: case report and mechanistic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We report a young adult male with recurrent episodes of muscle pain and
cramping, in whom genetic testing identified two heterozygous OBSCN
variants (c.20292C>A and c.708del).
explanation: >-
A further patient with two OBSCN variants (a nonsense and a frameshift)
and recurrent exertional muscle symptoms.
- reference: PMID:33438037
reference_title: "When is an obscurin variant pathogenic? The impact of Arg4344Gln and Arg4444Trp variants on protein-protein interactions and protein stability."
supports: NO_EVIDENCE
evidence_source: IN_VITRO
snippet: >-
We found no changes in titin binding and thermostability for both
variants and modestly increased affinities of PLN for R4344Q and R4444W.
explanation: >-
Does not bear on the loss-of-function claim of this record. It is cited
as the source for the caution in the notes that OBSCN missense variants
should not be assumed pathogenic: two cardiomyopathy-associated
missense variants left titin binding and domain stability unchanged.
variants:
- name: p.Gln7062*
description: >-
NM_001386125.1:c.21184C>T, a nonsense variant found in trans with the
intronic c.15610+12C>T in an 11-year-old girl with exercise-induced
rhabdomyolysis. Her mother, homozygous for c.21184C>T, had
exercise-induced myalgia and a creatine kinase over 2000.
evidence:
- reference: PMID:40186404
reference_title: "Identification of Compound Heterozygous Variants in OBSCN Gene Associated With Rhabdomyolysis: A Case Report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The fact that the mother harbored the homozygous OBSCN variant and
also showed symptoms of exercise-induced myalgia provides further
support for its pathogenicity.
explanation: >-
A homozygous carrier of the nonsense allele is also symptomatic.
pathophysiology:
- name: Obscurin Loss of Function
description: >-
Biallelic truncating OBSCN variants reduce the transcript and remove
obscurin protein from skeletal muscle. Obscurin normally binds titin and
myomesin at the M-band, and through its C-terminus binds the sarcoplasmic
reticulum protein sAnk1.5 and ankyrin-B, linking the myofibril to the
sarcoplasmic reticulum and to the subsarcolemmal cytoskeleton.
biological_scale: MOLECULAR
genes:
- preferred_term: OBSCN
term:
id: hgnc:15719
label: OBSCN
genetic_context:
variant_origin: GERMLINE
functional_impact_category: LOSS_OF_FUNCTION
molecular_functions:
- preferred_term: ankyrin binding
modifier: DECREASED
term:
id: GO:0030506
label: ankyrin binding
evidence:
- reference: PMID:34957489
reference_title: "Bi-allelic loss-of-function OBSCN variants predispose individuals to severe recurrent rhabdomyolysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We show reduced expression of OBSCN and loss of obscurin protein in
patient muscle.
explanation: >-
Obscurin is lost from patient muscle.
- reference: PMID:41645489
reference_title: "Myopathy With Exercise-Induced Intolerance due to Novel Biallelic Variants in OBSCN-A Clinical, Morphological and Molecular Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
OBSCN transcript levels were significantly decreased in the patient's
muscle
explanation: >-
A frameshift allele lowers OBSCN transcript in patient muscle,
consistent with nonsense-mediated decay.
- reference: PMID:12527750
reference_title: "Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles."
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
We report here that ank1.5, a small splice variant of the ank1 gene
localized on the sarcoplasmic reticulum membrane, is capable of
interacting with a sequence of 25 aa located at the COOH terminus of
obscurin.
explanation: >-
Normal function: the obscurin C-terminus binds the sarcoplasmic
reticulum ankyrin sAnk1.5, the binding activity bound on this node.
downstream:
- target: Longitudinal Sarcoplasmic Reticulum Disorganization
causal_link_type: DIRECT
evidence:
- reference: PMID:19584095
reference_title: "Obscurin determines the architecture of the longitudinal sarcoplasmic reticulum."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Lack of obscurin in cross-striated muscles leads to changes in
longitudinal SR architecture and disruption of small ankyrin-1.5
(sAnk1.5) expression and localization.
explanation: >-
In knockout mice, loss of obscurin disorganizes the longitudinal
sarcoplasmic reticulum.
- target: Sarcolemmal Fragility
causal_link_type: DIRECT
evidence:
- reference: PMID:23420875
reference_title: "Obscurin is required for ankyrinB-dependent dystrophin localization and sarcolemma integrity."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
In obscurin KO mice, localization at costameres of dystrophin, but not
of β-dystroglycan, was altered, and the subsarcolemma microtubule
cytoskeleton was disrupted.
explanation: >-
Without obscurin, ankyrin-B and dystrophin are mislocalized and the
subsarcolemmal cytoskeleton is disrupted.
- target: Exercise-Induced Sarcomeric M-Band Disorganization
causal_link_type: DIRECT
evidence:
- reference: PMID:27784675
reference_title: "Exercise-induced alterations and loss of sarcomeric M-line organization in the diaphragm muscle of obscurin knockout mice."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
obscurin is required for the maintenance of morphological and
ultrastructural integrity of skeletal muscle fibers against damage
induced by intense mechanical stress
explanation: >-
Without obscurin, sarcomere structure fails under intense exercise
in mice.
- name: Longitudinal Sarcoplasmic Reticulum Disorganization
description: >-
Without its obscurin anchor, sAnk1.5 is lost or mislocalized and the
longitudinal sarcoplasmic reticulum around the myofibril is disorganized.
In patient myoblasts the reticulum holds less calcium than control cells
under starvation, which the authors attribute to less efficient calcium
re-uptake or storage when metabolism is limited.
biological_scale: CELLULAR
cell_types:
- preferred_term: skeletal muscle fiber
term:
id: CL:0008002
label: skeletal muscle fiber
biological_processes:
- preferred_term: calcium ion import into sarcoplasmic reticulum
modifier: DECREASED
term:
id: GO:1990036
label: calcium ion import into sarcoplasmic reticulum
notes: >-
The calcium-uptake binding records the authors' interpretation of a
reduced reticulum calcium content in starved patient myoblasts. Uptake
was not measured directly, so the decrease is inferred.
evidence:
- reference: PMID:34957489
reference_title: "Bi-allelic loss-of-function OBSCN variants predispose individuals to severe recurrent rhabdomyolysis."
supports: SUPPORT
evidence_source: IN_VITRO
directness: INDIRECT
snippet: >-
Patient cultured myoblasts appear more susceptible to starvation as
evidenced by a greater decreased in sarcoplasmic reticulum Ca2+ content
compared to control myoblasts.
explanation: >-
Patient cells hold less calcium in the sarcoplasmic reticulum under
metabolic stress. Graded INDIRECT because reduced uptake is the
authors' inference from reduced content.
- reference: PMID:19584095
reference_title: "Obscurin determines the architecture of the longitudinal sarcoplasmic reticulum."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Lack of obscurin in cross-striated muscles leads to changes in
longitudinal SR architecture and disruption of small ankyrin-1.5
(sAnk1.5) expression and localization.
explanation: >-
Structural change in the reticulum in obscurin-knockout mice.
downstream:
- target: Exercise-Induced Myofiber Breakdown
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
evidence:
- reference: PMID:34957489
reference_title: "Bi-allelic loss-of-function OBSCN variants predispose individuals to severe recurrent rhabdomyolysis."
supports: SUPPORT
evidence_source: IN_VITRO
directness: INDIRECT
snippet: >-
This likely reflects a lower efficiency when pumping Ca2+ back into
the sarcoplasmic reticulum and/or a decrease in Ca2+ sarcoplasmic
reticulum storage ability when metabolism is diminished.
explanation: >-
The authors propose that weaker calcium handling under metabolic load
contributes to myofiber breakdown during exertion. The link to
rhabdomyolysis is an inference, not a measurement.
- name: Sarcolemmal Fragility
description: >-
Obscurin targets ankyrin-B to the M-band. Without it, dystrophin is
mislocalized at costameres, the subsarcolemmal microtubule network is
disrupted, and the sarcolemma becomes fragile, so exercise damages the
membrane more than in wild-type muscle. Shown in knockout mice; patient
muscle shows reduced ankyrin-1 and ankyrin-2 by proteomics.
biological_scale: CELLULAR
conforms_to: "sarcolemmal_fragility_myofiber_necrosis#Sarcolemmal Mechanical Fragility"
cell_types:
- preferred_term: skeletal muscle fiber
term:
id: CL:0008002
label: skeletal muscle fiber
evidence:
- reference: PMID:23420875
reference_title: "Obscurin is required for ankyrinB-dependent dystrophin localization and sarcolemma integrity."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
these mutant mice displayed marked sarcolemmal fragility and reduced
muscle exercise tolerance
explanation: >-
Obscurin-knockout mice have a fragile sarcolemma and poor exercise
tolerance.
- reference: PMID:41645489
reference_title: "Myopathy With Exercise-Induced Intolerance due to Novel Biallelic Variants in OBSCN-A Clinical, Morphological and Molecular Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In contrast, the decreased proteins impact extrasarcomeric cytoskeleton
processes (ANK1 and ANK2)
explanation: >-
Patient muscle has less ankyrin-1 and ankyrin-2, the obscurin partners
that link the myofibril to membranes.
- reference: PMID:31098411
reference_title: "Murine obscurin and Obsl1 have functionally redundant roles in sarcolemmal integrity, sarcoplasmic reticulum organization, and muscle metabolism."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
directness: INDIRECT
snippet: >-
Only deletion of both proteins and removal of their functional
redundancy revealed their roles for sarcolemmal stability and
sarcoplasmic reticulum organization.
explanation: >-
Obscurin acts in sarcolemmal stability, but in this study the effect
was clear only when its paralog Obsl1 was also removed. Graded
INDIRECT because the double knockout is not the human genotype.
notes: >-
The two mouse studies disagree on how much a single Obscn knockout
shows. PMID:23420875 reports marked sarcolemmal fragility in obscurin
knockouts, while PMID:31098411 describes the single knockout as benign
and needed an Obsl1 co-deletion to reveal the membrane defect. OBSL1
redundancy may also explain why patients are well between episodes.
downstream:
- target: Exercise-Induced Myofiber Breakdown
causal_link_type: DIRECT
evidence:
- reference: PMID:23420875
reference_title: "Obscurin is required for ankyrinB-dependent dystrophin localization and sarcolemma integrity."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
these mutant mice displayed marked sarcolemmal fragility and reduced
muscle exercise tolerance
explanation: >-
The fragile membrane is damaged by exercise in the knockout.
- name: Exercise-Induced Sarcomeric M-Band Disorganization
description: >-
Under intense mechanical load, obscurin-deficient fibers lose the regular
M-band and H-zone structure of the sarcomere. Patient muscle shows
myofibrillar disintegration with M- and Z-band disruption and core-like
central lesions containing desmin aggregates.
biological_scale: CELLULAR
cell_types:
- preferred_term: skeletal muscle fiber
term:
id: CL:0008002
label: skeletal muscle fiber
evidence:
- reference: PMID:27784675
reference_title: "Exercise-induced alterations and loss of sarcomeric M-line organization in the diaphragm muscle of obscurin knockout mice."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
electron microscopy revealed that, in the diaphragm of exercised
obscurin KO mice, but not in the hindlimb muscles, both M-line and
H-zone of sarcomeres appeared wavy and less defined
explanation: >-
Exercise disorganizes the M-band in obscurin-knockout diaphragm.
- reference: PMID:41645489
reference_title: "Myopathy With Exercise-Induced Intolerance due to Novel Biallelic Variants in OBSCN-A Clinical, Morphological and Molecular Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
disruption of the myofibrillar structure with disruption of the M‐ and
Z‐bands
explanation: >-
The same ultrastructural lesion in a patient biopsy.
downstream:
- target: Exercise-Induced Myofiber Breakdown
causal_link_type: DIRECT
evidence:
- reference: PMID:27784675
reference_title: "Exercise-induced alterations and loss of sarcomeric M-line organization in the diaphragm muscle of obscurin knockout mice."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Histological analysis indicated that heavy exercise induced leukocyte
infiltration, fibrotic connective tissue deposition, and
hypercontractures in the diaphragm of KO mice.
explanation: >-
Exercise injures obscurin-deficient muscle in mice.
- name: Exercise-Induced Myofiber Breakdown
description: >-
Intense exercise, and sometimes fever, triggers breakdown of
obscurin-deficient myofibers. Their contents, including creatine kinase
and myoglobin, leak into the blood, producing rhabdomyolysis.
biological_scale: TISSUE
conforms_to: "sarcolemmal_fragility_myofiber_necrosis#Myofiber Necrosis"
cell_types:
- preferred_term: skeletal muscle fiber
term:
id: CL:0008002
label: skeletal muscle fiber
evidence:
- reference: PMID:38159459
reference_title: "Novel OBSCN variants associated with a risk to exercise-intolerance and rhabdomyolysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Obscurin-deficient muscle fibers seem to have increased susceptibility
to damage triggered by exercise that may lead to rhabdomyolysis.
explanation: >-
The authors' reading of their two patients: exercise damages
obscurin-deficient fibers.
downstream:
- target: Exercise-induced rhabdomyolysis
causal_link_type: DIRECT
evidence:
- reference: PMID:40186404
reference_title: "Identification of Compound Heterozygous Variants in OBSCN Gene Associated With Rhabdomyolysis: A Case Report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: >-
Deficiency of obscurin increases the risk of rhabdomyolysis by making
muscle fibers more sensitive to exercise‐induced injury and decreasing
membrane stability
explanation: >-
Links exercise-induced fiber injury to rhabdomyolysis. The sentence
summarizes earlier work rather than this case report's own data.
- target: Elevated circulating creatine kinase activity
causal_link_type: DIRECT
evidence:
- reference: PMID:40186404
reference_title: "Identification of Compound Heterozygous Variants in OBSCN Gene Associated With Rhabdomyolysis: A Case Report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Clinically, the patient presented with exercise-induced rhabdomyolysis
accompanied by significant serum creatine kinase elevation
explanation: >-
Fiber breakdown releases creatine kinase into serum.
- target: Myoglobinuria
causal_link_type: DIRECT
evidence:
- reference: PMID:38159459
reference_title: "Novel OBSCN variants associated with a risk to exercise-intolerance and rhabdomyolysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Here we reported two young patients with a history of cramps,
myalgia, exercise intolerance, rhabdomyolysis, and myoglobinuria
explanation: >-
Myoglobin released from damaged fibers appears in the urine.
- target: Exercise-induced myalgia
causal_link_type: DIRECT
evidence:
- reference: PMID:40186404
reference_title: "Identification of Compound Heterozygous Variants in OBSCN Gene Associated With Rhabdomyolysis: A Case Report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Loss‐of‐function variants of OBSCN have been shown to cause
exercise‐induced rhabdomyolysis (Cabrera‐Serrano et al. 2021;
Zemorshidi et al. 2024), such as myalgia, cramps, and significant
elevations in serum CK.
explanation: >-
Myalgia is named among the manifestations of the exercise-induced
fiber breakdown.
phenotypes:
- name: Exercise-induced rhabdomyolysis
category: Musculoskeletal
frequency: VERY_FREQUENT
description: >-
Recurrent, often severe rhabdomyolysis triggered mainly by high-intensity
exercise, with onset usually in childhood or the teenage years. One
reported patient with biallelic variants had cramps and myalgia without
rhabdomyolysis.
phenotype_term:
preferred_term: Exercise-induced rhabdomyolysis
term:
id: HP:0009045
label: Exercise-induced rhabdomyolysis
onset:
onset_category: JUVENILE
notes: >-
Onset usually in the teenage years (PMID:34957489). The reported
patients were 11 to 39 years old.
evidence:
- reference: PMID:34957489
reference_title: "Bi-allelic loss-of-function OBSCN variants predispose individuals to severe recurrent rhabdomyolysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Here we present six patients who presented with severe and recurrent
rhabdomyolysis, usually with onset in the teenage years
explanation: >-
Recurrent rhabdomyolysis is the defining feature of the founding
series.
- reference: PMID:40186404
reference_title: "Identification of Compound Heterozygous Variants in OBSCN Gene Associated With Rhabdomyolysis: A Case Report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The main feature for these patients was childhood or adolescent onset,
with exercise‐ or heat‐induced rhabdomyolysis
explanation: >-
Summary of the nine patients reported to date.
- name: Exercise-induced myalgia
category: Musculoskeletal
frequency: VERY_FREQUENT
description: >-
Muscle pain after exertion, reported in eight of nine patients
summarized in PMID:40186404, and the presenting symptom in patients
without frank rhabdomyolysis.
phenotype_term:
preferred_term: Exercise-induced myalgia
term:
id: HP:0003738
label: Exercise-induced myalgia
evidence:
- reference: PMID:40186404
reference_title: "Identification of Compound Heterozygous Variants in OBSCN Gene Associated With Rhabdomyolysis: A Case Report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
accompanied by exercise intolerance (7/9) and myalgia (8/9)
explanation: >-
Myalgia in eight of nine reported patients.
- reference: PMID:41645489
reference_title: "Myopathy With Exercise-Induced Intolerance due to Novel Biallelic Variants in OBSCN-A Clinical, Morphological and Molecular Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We present a 22‐year‐old woman who experienced muscle stiffness, myalgia
and cramps in her thighs and gluteal muscles after performing
high‐intensity sports (roundnet).
explanation: >-
Exercise-induced myalgia in a patient with biallelic variants.
- name: Exercise-induced muscle cramps
category: Musculoskeletal
description: >-
Cramps after exertion, in three of nine patients summarized in
PMID:40186404 and in later reports.
phenotype_term:
preferred_term: Exercise-induced muscle cramps
term:
id: HP:0003710
label: Exercise-induced muscle cramps
evidence:
- reference: PMID:34957489
reference_title: "Bi-allelic loss-of-function OBSCN variants predispose individuals to severe recurrent rhabdomyolysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
other features included a history of myalgia and muscle cramps
explanation: >-
Cramps are part of the phenotype in the founding series.
- reference: PMID:41645489
reference_title: "Myopathy With Exercise-Induced Intolerance due to Novel Biallelic Variants in OBSCN-A Clinical, Morphological and Molecular Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Patients harbouring biallelic OBSCN nonsense variants can also present
with exercise‐induced cramps and myalgia, as observed in our patient
without developing the full clinical picture of rhabdomyolysis
explanation: >-
Exercise-induced cramps, sometimes without rhabdomyolysis.
- name: Exercise intolerance
category: Musculoskeletal
frequency: FREQUENT
description: >-
Reduced tolerance of strenuous exercise, in seven of nine patients
summarized in PMID:40186404.
phenotype_term:
preferred_term: Exercise intolerance
term:
id: HP:0003546
label: Exercise intolerance
evidence:
- reference: PMID:40186404
reference_title: "Identification of Compound Heterozygous Variants in OBSCN Gene Associated With Rhabdomyolysis: A Case Report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
accompanied by exercise intolerance (7/9) and myalgia (8/9)
explanation: >-
Exercise intolerance in seven of nine reported patients.
- name: Elevated circulating creatine kinase activity
category: Laboratory
frequency: VERY_FREQUENT
description: >-
Very high serum creatine kinase during episodes, with a reported mean
over 275,000 IU/L and a maximum of 603,000 IU/L. Creatine kinase can
stay raised for days after symptoms improve.
phenotype_term:
preferred_term: Elevated circulating creatine kinase activity
term:
id: HP:0003236
label: Elevated circulating creatine kinase activity
evidence:
- reference: PMID:40186404
reference_title: "Identification of Compound Heterozygous Variants in OBSCN Gene Associated With Rhabdomyolysis: A Case Report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
All patients presented with significant elevation of serum CK (mean
value over 275,000 IU/L and maximum up to 603,000 IU/L)
explanation: >-
Marked creatine kinase elevation in all nine reported patients.
- name: Myoglobinuria
category: Renal
description: >-
Myoglobin in the urine during rhabdomyolysis episodes.
phenotype_term:
preferred_term: Myoglobinuria
term:
id: HP:0002913
label: Myoglobinuria
evidence:
- reference: PMID:38159459
reference_title: "Novel OBSCN variants associated with a risk to exercise-intolerance and rhabdomyolysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Here we reported two young patients with a history of cramps, myalgia,
exercise intolerance, rhabdomyolysis, and myoglobinuria
explanation: >-
Myoglobinuria in both patients of this report.
- name: Acute kidney injury
category: Renal
frequency: FREQUENT
description: >-
Renal failure complicating rhabdomyolysis, in three of nine reported
patients.
phenotype_term:
preferred_term: Acute kidney injury
term:
id: HP:0001919
label: Acute kidney injury
evidence:
- reference: PMID:40186404
reference_title: "Identification of Compound Heterozygous Variants in OBSCN Gene Associated With Rhabdomyolysis: A Case Report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Renal failure occurred in 3 patients (3/9), but cardiac function was
normal in all patients.
explanation: >-
Kidney injury in a third of reported patients; no cardiac involvement.
- name: Increased variability in muscle fiber diameter
category: Musculoskeletal
description: >-
Muscle biopsy findings are variable: fiber-size variation, internal
nuclei, type 2 fiber predominance, ring and necrotic fibers, and
core-like lesions.
phenotype_term:
preferred_term: Increased variability in muscle fiber diameter
term:
id: HP:0003557
label: Increased variability in muscle fiber diameter
evidence:
- reference: PMID:41645489
reference_title: "Myopathy With Exercise-Induced Intolerance due to Novel Biallelic Variants in OBSCN-A Clinical, Morphological and Molecular Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
quote_role: REVIEW_SYNTHESIS
snippet: >-
Previous studies of OBSCN‐associated myopathy revealed variable muscle
pathology, including increased variation in muscle fibre size,
internalised nuclei, ring fibres, necrotic fibres, predominance of type
2 muscle fibres and core‐like pathology
explanation: >-
Summarizes biopsy findings across earlier reports.
environmental:
- name: Strenuous exercise
description: >-
High-intensity exercise is the main trigger of rhabdomyolysis episodes.
Fever and heat are less common triggers.
exposure_term:
preferred_term: exposure to strenuous exercise
term:
id: ECTO:6000031
label: exposure to strenuous exercise
evidence:
- reference: PMID:41645489
reference_title: "Myopathy With Exercise-Induced Intolerance due to Novel Biallelic Variants in OBSCN-A Clinical, Morphological and Molecular Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Symptoms are mainly induced by high-intensity sports.
explanation: >-
High-intensity exercise triggers symptoms.
influences_mechanisms:
- target: Exercise-Induced Myofiber Breakdown
environmental_effect: TRIGGERS
causal_link_type: DIRECT
description: >-
Intense exercise precipitates fiber breakdown in obscurin-deficient
muscle.
evidence:
- reference: PMID:41645489
reference_title: "Myopathy With Exercise-Induced Intolerance due to Novel Biallelic Variants in OBSCN-A Clinical, Morphological and Molecular Analysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In the majority of these patients, cramps, myalgia and rhabdomyolysis
were triggered by high‐intensity sports
explanation: >-
Exercise triggers the episodes in most reported patients.
diagnosis:
- name: Exome sequencing
diagnosis_term:
preferred_term: whole exome sequencing
term:
id: NCIT:C101295
label: Whole Exome Sequencing
description: >-
Reported cases were found by exome or panel sequencing of patients with
recurrent rhabdomyolysis.
evidence:
- reference: PMID:40186404
reference_title: "Identification of Compound Heterozygous Variants in OBSCN Gene Associated With Rhabdomyolysis: A Case Report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We performed whole exome sequencing on a patient with exercise-induced
rhabdomyolysis to identify possible causative gene variants.
explanation: >-
Diagnosis by exome sequencing.
treatments:
- name: Fluid therapy during acute rhabdomyolysis
description: >-
There is no OBSCN-directed therapy. Acute episodes are treated as for
other causes of rhabdomyolysis, with intravenous fluids and urine
alkalinization to protect the kidneys.
therapeutic_modality: OTHER
treatment_term:
preferred_term: Fluid Therapy
term:
id: NCIT:C116537
label: Fluid Therapy
target_phenotypes:
- preferred_term: Exercise-induced rhabdomyolysis
term:
id: HP:0009045
label: Exercise-induced rhabdomyolysis
evidence:
- reference: PMID:40186404
reference_title: "Identification of Compound Heterozygous Variants in OBSCN Gene Associated With Rhabdomyolysis: A Case Report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The patient received routine pediatric care, including urine
alkalinization, fluid replacement, and antioxidant therapy with vitamin
C. Her symptoms significantly improved after five days of treatment
explanation: >-
Supportive fluid treatment of an acute episode, in one patient.
- name: Avoidance of strenuous exercise
description: >-
Patients are advised to avoid strenuous physical activity, the main
trigger of episodes. No controlled study of this has been reported.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: Exercise Counseling
term:
id: NCIT:C101235
label: Exercise Counseling
evidence:
- reference: PMID:40186404
reference_title: "Identification of Compound Heterozygous Variants in OBSCN Gene Associated With Rhabdomyolysis: A Case Report."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
given the persistently high CK levels, she was advised to avoid
strenuous physical activity
explanation: >-
Trigger avoidance was advised in this case.
animal_models:
- name: Obscurin knockout mouse
species: Mouse
genotype: Obscn-/-
publication: PMID:23420875
description: >-
Obscn-null mice have a disorganized longitudinal sarcoplasmic reticulum,
mislocalized ankyrin-B and dystrophin, sarcolemmal fragility, reduced
running endurance and exercise-induced muscle damage, worst in the
diaphragm and with age.
modeled_mechanisms:
- target: Sarcolemmal Fragility
relationship: RECAPITULATES
fidelity: MODERATE
model_scale: TISSUE
description: >-
The knockout shows the membrane fragility and exercise intolerance
proposed to underlie the human disease.
limitations: >-
Frank rhabdomyolysis with myoglobinuria has not been reported in the
mouse. Exercise injury is most marked in the diaphragm, not the limb
muscles affected in patients.
evidence:
- reference: PMID:23420875
reference_title: "Obscurin is required for ankyrinB-dependent dystrophin localization and sarcolemma integrity."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
these mutant mice displayed marked sarcolemmal fragility and reduced
muscle exercise tolerance
explanation: >-
The knockout reproduces the fragility node.
- target: Exercise-Induced Sarcomeric M-Band Disorganization
relationship: PARTIALLY_RECAPITULATES
fidelity: MODERATE
model_scale: TISSUE
limitations: >-
Seen in the diaphragm but not the hindlimb muscles of exercised mice.
evidence:
- reference: PMID:27784675
reference_title: "Exercise-induced alterations and loss of sarcomeric M-line organization in the diaphragm muscle of obscurin knockout mice."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
electron microscopy revealed that, in the diaphragm of exercised
obscurin KO mice, but not in the hindlimb muscles, both M-line and
H-zone of sarcomeres appeared wavy and less defined
explanation: >-
M-band disorganization after exercise, limited to the diaphragm.
discussions:
- discussion_id: rhabdo1_mouse_model_mismatch
prompt: >-
Why does obscurin loss cause trigger-dependent recurrent rhabdomyolysis
in people, when obscurin-knockout mice show at most mild, mainly
diaphragmatic exercise injury and no frank rhabdomyolysis?
kind: HUMAN_MODEL_MISMATCH
status: OPEN
attaches_to:
- pathophysiology#Sarcolemmal Fragility
- pathophysiology#Exercise-Induced Myofiber Breakdown
- animal_models#Obscurin knockout mouse
rationale: >-
The membrane and sarcoplasmic reticulum defects proposed for the human
disease come mainly from mice, where the paralog Obsl1 compensates for
obscurin loss and the single knockout is mild. The only human functional
readout is reduced sarcoplasmic reticulum calcium in starved patient
myoblasts. Whether OBSL1 compensates less in human skeletal muscle, or
the human trigger load is simply larger, is untested.
evidence:
- reference: PMID:31098411
reference_title: "Murine obscurin and Obsl1 have functionally redundant roles in sarcolemmal integrity, sarcoplasmic reticulum organization, and muscle metabolism."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
skeletal muscle-specific Obsl1 knockouts show a benign phenotype similar
to obscurin knockouts
explanation: >-
Single obscurin knockout mice are mild, unlike the human disease.
Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.
Review round 1: Rhabdomyolysis Susceptibility To 1 · 2026-10-27T18:54:24Z · View source
Addressed optional review suggestions on PR 15754. Replaced the snippet on the Exercise-Induced Myofiber Breakdown to Exercise-induced myalgia edge, which named the triggers but not myalgia, with the PMID:40186404 sentence listing myalgia among the manifestations. Added genetic evidence from PMID:40813169 (a further patient with two OBSCN variants) and PMID:33438037 (two cardiomyopathy-associated missense variants left titin binding and stability unchanged), both previously named only in notes. PMID:33438037 is graded NO_EVIDENCE, since it supports the missense caution rather than the loss-of-function claim of the record. Did not add further variants, since the founding-series alleles are listed only in the deep-research report and not in the cached abstracts, and did not add a fever environmental entry, since ECTO has no fever exposure in the term cache and fever is a host state rather than an exposure. Snippets 48/48 verified.
Create: Rhabdomyolysis Susceptibility To 1 (OBSCN, MONDO:0859371) · 2026-10-27T18:30:42Z · View source
New entry for autosomal recessive OBSCN loss-of-function rhabdomyolysis susceptibility (RHABDO1, OMIM:620235). Literature was gathered from PubMed (the founding Brain 2022 series, four later case reports, and the obscurin-knockout mouse studies), and an OpenScientist deep-research report was run and screened with just preflight-dr. Preflight confirmed the entity but flagged that the report labels OBSCN as HGNC:16542, which is PPIAP2; the entry binds hgnc:15719 from the term cache instead. From the report, the Obscn/Obsl1 double-knockout study (PMID:31098411) and the obscurin missense caution (PMID:33438037) were added; the report's HPO annotations without a citable source (distal weakness, acylcarnitine abnormality) and its unsourced fasting trigger were not taken. The pathograph runs from obscurin loss through sarcoplasmic reticulum disorganization, sarcolemmal fragility and exercise-induced M-band disorganization to myofiber breakdown, conforming to the sarcolemmal_fragility_myofiber_necrosis module at its fragility and necrosis nodes. A HUMAN_MODEL_MISMATCH discussion records that knockout mice do not develop rhabdomyolysis. Validated with just validate, validate-terms, count-verified-snippets (46/46), and the offline KB gates.
Disease: Rhabdomyolysis, Susceptibility To, 1 (RHABDO1) MONDO ID: MONDO:0859371 · OMIM: 620235 · Causal gene: OBSCN (obscurin; HGNC:16542; UniProt Q5VST9; chromosome 1q42) Category: Mendelian (autosomal recessive)
Gene identity (stated up front): The causal gene for Rhabdomyolysis Susceptibility To 1 is OBSCN, which encodes obscurin, a giant (~800 kDa) sarcomeric cytoskeletal/signaling protein. This report concerns the OBSCN-related entity (OMIM 620235), not rhabdomyolysis caused by other genes (e.g., RYR1, LPIN1, CPT2, PYGM, ANO5, fatty-acid-oxidation genes).
Rhabdomyolysis, Susceptibility To, 1 (RHABDO1) is a rare Mendelian skeletal-muscle disorder caused by bi-allelic loss-of-function (LOF) variants in OBSCN, the gene encoding obscurin — a giant (~800 kDa) modular sarcomeric signaling and structural protein that physically links the contractile sarcomere (at the M-band and Z-disk) to the sarcoplasmic reticulum (SR). The disease was defined by Cabrera-Serrano and colleagues (Brain, 2022), who identified 10 bi-allelic LOF OBSCN variants in six unrelated patients with severe, recurrent exertional rhabdomyolysis and demonstrated reduced OBSCN expression and loss of obscurin protein in patient muscle (PMID: 34957489). This case series established OMIM 620235.
The core clinical picture is teenage-onset, recurrent, severe rhabdomyolysis precipitated by metabolic or mechanical triggers (strenuous exercise, fasting, febrile illness), accompanied by myalgia, muscle cramps, exercise intolerance, markedly elevated serum creatine kinase (CK), and myoglobinuria that risks acute kidney injury (AKI). A distinguishing feature is cardiac sparing — despite prior literature linking OBSCN to cardiomyopathy, RHABDO1 patients consistently lack cardiomyopathy and have normal cardiac examinations. The mechanistic model, supported by patient myoblast studies and mouse Obscn/Obsl1 models, is that obscurin loss disorganizes the SR and impairs Ca²⁺ re-uptake/storage, sensitizing myofibers to metabolic and mechanical stress and precipitating episodic myofiber breakdown.
Genetically, OBSCN is not constrained against heterozygous LOF in gnomAD (pLI ≈ 0, LOEUF ≈ 0.94), consistent with recessive inheritance in which a single LOF allele is tolerated. In ClinVar, truncating OBSCN variants (nonsense/frameshift) associated with rhabdomyolysis are classified Pathogenic/Likely-pathogenic, whereas missense variants are predominantly Variants of Uncertain Significance (VUS). There is no gene-specific therapy; management is supportive (aggressive IV fluid resuscitation, electrolyte and renal monitoring during crises) combined with trigger avoidance and genetic counseling. This report synthesizes evidence across the defining human case series, three additional case reports, gnomAD constraint data, ClinVar classifications, UniProt domain architecture, Monarch/HPO phenotype annotations, and mouse models.
Overview. RHABDO1 is an autosomal-recessive susceptibility to recurrent rhabdomyolysis — acute skeletal-muscle fiber breakdown with release of intracellular contents (CK, myoglobin, electrolytes) into the circulation. Affected individuals are often asymptomatic or only mildly symptomatic between episodes but develop severe crises when exposed to triggers. The condition is a genetic susceptibility rather than a continuously progressive myopathy: episodes are trigger-dependent and episodic, with normal or near-normal muscle strength between attacks in most patients.
Key identifiers.
| Resource | Identifier |
|---|---|
| OMIM | 620235 (Rhabdomyolysis, susceptibility to, 1) |
| MONDO | MONDO:0859371 |
| Causal gene | OBSCN (HGNC:16542; NCBI Gene; Ensembl ENSG00000154358) |
| Protein | Obscurin, UniProt Q5VST9 |
| Cytoband | 1q42 |
| Orphanet / ICD-10 / ICD-11 / MeSH | No dedicated RHABDO1-specific code identified; rhabdomyolysis maps to ICD-10 M62.82 and MeSH D012206 (Rhabdomyolysis) |
Synonyms / alternative names. No formal synonyms are recorded in the template. The condition is referred to descriptively in the literature as "OBSCN-related rhabdomyolysis," "obscurin-deficiency rhabdomyolysis," and "bi-allelic OBSCN loss-of-function rhabdomyolysis."
Information source. The knowledge base here is derived from aggregated disease-level resources (OMIM, ClinVar, gnomAD, HPO/Monarch, UniProt) and individual patient case reports/series in the primary literature — not from a large EHR cohort. The total reported patient count worldwide is small (roughly a dozen across the defining series and subsequent case reports).
Disease causal factors. The primary cause is genetic: bi-allelic (homozygous or compound-heterozygous) loss-of-function variants in OBSCN. The defining study identified 10 bi-allelic LOF OBSCN variants across six unrelated patients (PMID: 34957489). Disease expression, however, is gene–environment dependent: the genetic lesion establishes susceptibility, while an environmental/metabolic trigger (exertion, fasting, fever/infection) precipitates each acute episode.
Genetic risk factors. The causal variants are LOF alleles in OBSCN (nonsense, frameshift, canonical splice-site). Because OBSCN tolerates heterozygous LOF (gnomAD pLI ≈ 0), two defective alleles are required for disease. No established modifier genes are proven for RHABDO1 specifically, though the paralogue OBSL1 (obscurin-like 1) provides functional redundancy in muscle (relevant to mechanism; see Section 6).
Environmental risk factors / triggers. Based on the clinical descriptions: strenuous or unaccustomed exercise, fasting/caloric deprivation, febrile illness/infection, and likely dehydration and heat stress (the classic precipitants of exertional rhabdomyolysis generally). Patient myoblasts were shown to be more susceptible to starvation specifically (PMID: 34957489), providing a direct link between a metabolic trigger and cellular vulnerability.
Protective factors. No validated genetic protective variants or protective alleles are reported. By inference, avoidance of triggers (adequate hydration, avoiding prolonged fasting, graded rather than sudden intense exercise, prompt management of febrile illness) is protective against episodes. No nutritional or pharmacologic protective factor has been established.
Gene–environment interactions. RHABDO1 is a prototypical gene × environment disorder: the OBSCN LOF genotype lowers the threshold at which metabolic/mechanical stress triggers Ca²⁺ dysregulation and myofiber breakdown. The starvation-sensitivity of patient myoblasts is the best-characterized GxE link (PMID: 34957489).
The official Monarch/HPO disease–phenotype annotation set for MONDO:0859371 comprises 10 terms, spanning episodic clinical features, laboratory abnormalities, and muscle-biopsy histopathology.
| Phenotype | HPO term | Type | Notes |
|---|---|---|---|
| Elevated circulating creatine kinase | HP:0003236 | Laboratory abnormality | Markedly elevated during episodes (CK can reach hundreds of thousands U/L in rhabdomyolysis) |
| Rhabdomyolysis | HP:0003201 | Clinical sign | Core defining feature; recurrent/episodic |
| Myalgia | HP:0003326 | Symptom | Muscle pain, often with cramps |
| Exercise intolerance | HP:0003546 | Symptom | Common trigger-associated complaint |
| Renal insufficiency | HP:0000083 | Laboratory/clinical | Secondary to myoglobinuria (AKI risk) |
| Increased variability in muscle fiber diameter | HP:0003557 | Histopathology | Muscle-biopsy finding |
| Centrally nucleated skeletal muscle fibers | HP:0003687 | Histopathology | Muscle-biopsy finding |
| Type 2 muscle fiber predominance | HP:0010602 | Histopathology | Muscle-biopsy finding |
| Distal muscle weakness | HP:0002460 | Clinical sign | Variable; not universal |
| Abnormal circulating fatty acylcarnitine concentration | HP:0012071 | Laboratory abnormality | Metabolic workup finding |
Phenotype characteristics. - Age of onset: typically teenage years (adolescence), as described in the defining series — "usually with onset in the teenage years" (PMID: 34957489). Subsequent reports describe young adults/young patients. - Severity: severe and recurrent episodes of rhabdomyolysis; variable between episodes and between individuals (variable expressivity). - Progression: episodic/relapsing, trigger-dependent; not a steadily progressive degenerative myopathy. Patients are often well between episodes. - Frequency among affected individuals: myalgia, muscle cramps, exercise intolerance and elevated CK are consistent features; cardiomyopathy is characteristically absent.
Cardiac sparing. Multiple reports emphasize no cardiomyopathy: the defining series found no cardiomyopathy despite prior OBSCN–cardiomyopathy associations and normal cardiac exams (PMID: 34957489); Zemorshidi et al. described two young patients "without any evidence of concomitant cardiomyopathy" (PMID: 38159459); Sun et al. reported edema on MRI "without significant muscle weakness or cardiac abnormalities" (PMID: 40186404).
Quality-of-life impact. No disease-specific EQ-5D/SF-36/PROMIS data exist for RHABDO1. By inference, QoL impact derives from recurrent painful episodes, hospitalizations for crises, exercise limitation, and anxiety about triggers; between episodes, function is often preserved.
Causal gene. OBSCN (obscurin), HGNC:16542, chromosome 1q42; Ensembl ENSG00000154358. OBSCN has 121 non-overlapping exons and encodes some of the largest known mRNAs in the human genome, undergoing extensive developmentally- and tissue-regulated alternative splicing (PMID: 40025502). The same gene underlies both a cardiomyopathy disease axis and the rhabdomyolysis axis, with isoform- and domain-specific effects.
Pathogenic variants (RHABDO1-associated). Pathogenic/likely-pathogenic variants are loss-of-function (nonsense, frameshift, canonical splice). Representative ClinVar entries (transcript NM_001386125.1), classified Pathogenic (P) or Likely-pathogenic (LP):
| cDNA | Protein | Type | ClinVar class |
|---|---|---|---|
| c.20788C>T | p.Gln6930Ter | Nonsense | Pathogenic |
| c.7485_7486insCCCGCCC | p.Thr2496fs | Frameshift | Pathogenic |
| c.5943C>A | p.Cys1981Ter | Nonsense | Likely pathogenic |
| c.25879_25880del | p.Lys8627fs | Frameshift | Likely pathogenic |
| c.20292C>G | p.Tyr6764Ter | Nonsense | Likely pathogenic |
| c.23841dup | p.Gly7948fs | Frameshift | Likely pathogenic |
| c.19607C>A | p.Ser6536Ter | Nonsense | Likely pathogenic |
| c.15307C>T | p.Gln5103Ter | Nonsense | Likely pathogenic |
| c.12859C>T | p.Gln4287Ter | Nonsense | Likely pathogenic |
Additional genotypes from case reports: compound heterozygous c.21184C>T (nonsense) + c.15610+12C>T (intronic splicing; absent from gnomAD_EAS) (PMID: 40186404); novel variants c.24822C>A and c.2653+1G>C (PMID: 38159459); and c.20292C>A + c.708del (PMID: 40813169).
Variant classification caveat. Missense, synonymous, and splice-region changes in the same rhabdomyolysis-annotated ClinVar set are largely VUS (e.g., p.Arg7149Pro, p.Val6753Leu, p.Trp1659Cys). This is reinforced by functional work showing that two cardiomyopathy-associated obscurin missense variants (R4344Q, R4444W) did not alter titin binding or domain thermostability and that R4344Q is present in 15% of African Americans, arguing against pathogenicity — a cautionary tale for over-calling OBSCN missense variants (PMID: 33438037). OBSCN has ~150 total P/LP ClinVar entries across all phenotypes.
Allele frequency / population constraint. gnomAD v2.1.1 constraint for OBSCN: pLI = 7.4×10⁻²²⁶ (≈ 0), observed/expected LOF (oe_lof) = 0.88 (90% CI 0.83–0.94; LOEUF 0.94), with 768 observed vs 870.9 expected LOF alleles; missense constraint low (mis_z = 0.53, oe_mis = 0.99). Interpretation: OBSCN is not depleted of heterozygous LOF variants, consistent with recessive inheritance where carriers are unaffected.
Somatic vs germline. All reported variants are germline. No somatic involvement is relevant to this disorder.
Functional consequences. Loss of function — reduced OBSCN expression and loss of obscurin protein in patient muscle (PMID: 34957489). This contrasts with proposed gain-of-function/dominant-negative mechanisms sometimes invoked for OBSCN cardiomyopathy variants.
Modifier genes / epigenetics / chromosomal abnormalities. No established modifier genes, epigenetic marks, or large-scale chromosomal abnormalities are described specifically for RHABDO1. OBSL1 redundancy is mechanistically relevant (Section 6). Alternative splicing of OBSCN may be regulated in part by BUB3 (PMID: 40025502).
Environmental / triggering factors. The disease requires an environmental trigger to produce episodes. Established/implicated precipitants: strenuous or unaccustomed physical exertion, fasting/starvation, febrile illness, and plausibly dehydration and heat. Patient myoblasts are specifically more susceptible to starvation (PMID: 34957489).
Lifestyle factors. Exercise intensity and pattern, hydration status, and fasting behavior modulate risk. There is no reported association with smoking, alcohol, or diet beyond the fasting trigger.
Infectious agents. No pathogen causes RHABDO1. However, febrile infections act as triggers of acute episodes — a general feature of metabolic/genetic rhabdomyolysis susceptibilities. (For context, infections such as SARS-CoV-2 can independently cause rhabdomyolysis, PMID: 34871534, but this is etiologically distinct from the OBSCN genetic susceptibility.)
Branch (cardiac, largely spared in RHABDO1): In the heart, obscurin loss produces a separate disease axis — reduced SR volume with preserved T-tubules, lower SERCA/PLB, dilated cardiomyopathy and arrhythmia susceptibility in mice (PMID: 40366302); domain-specific Ig58/59 deletion causes atrial remodeling and Ca²⁺-based arrhythmogenesis (PMID: 39804820). In human RHABDO1, however, the cardiac axis is not manifest (cardiac sparing), likely reflecting isoform/redundancy differences between skeletal and cardiac muscle.
Protein architecture (UniProt Q5VST9, canonical 7,968 aa). Obscurin contains ~55 Ig-like domains, 4 fibronectin type-III (Fn3) domains, a calmodulin-binding IQ motif (aa 4872–4901), a tandem SH3 (5600–5667)–DH (5693–5877)–PH (5895–6004) RhoGEF signaling module, and two C-terminal Ser/Thr protein kinase domains (PK1 6468–6721; PK2 7672–7924). The N-terminal Ig1–3 domains target obscurin to the M-band/Z-disk via interactions with titin and myomesin.
Sarcomere–SR linkage. Obscurin's N-terminus binds M-band titin and myomesin; downregulation of myomesin disrupts obscurin M-band integration (PMID: 18477606). Crystallographic work defines the titin M10–obsl1/obscurin Ig–Ig interface and shows that disease-linked titin M10 mutations disrupt this complex (PMID: 20133654). Obscurin's C-terminus binds the N-terminal Z-disk region of titin and coassembles during myofibrillogenesis; the protein carries IQ (Ca²⁺/calmodulin) and RhoGEF (G-protein) signaling modules (PMID: 11448995). The RhoGEF domain selectively activates RhoA at the M-band in skeletal muscle and responds to lengthening-contraction injury (PMID: 19605563).
Functional redundancy with OBSL1. Single deletion of obscurin or Obsl1 is tolerated in mouse muscle; only combined deletion reveals roles in sarcolemmal stability and SR organization (PMID: 31098411). This redundancy may explain variable expressivity and the relatively mild baseline state between episodes.
Metabolic / mitochondrial dimension. Combined Obsc/Obsl1 loss in heart altered metabolism, reduced Chchd3 (a MICOS complex protein), produced abnormal mitophagy and increased unfolded protein response (PMID: 40066567). The abnormal acylcarnitine finding (HP:0012071) and starvation-sensitivity in human myoblasts point to an energy-metabolism vulnerability that intersects with Ca²⁺ handling.
Ontology suggestions. - GO biological process: regulation of release of sequestered calcium ion into cytosol (GO:0051279); sarcomere organization (GO:0045214); muscle contraction (GO:0006936); Rho protein signal transduction (GO:0007266); striated muscle cell development (GO:0055002). - GO cellular component: sarcoplasmic reticulum (GO:0016529); M band (GO:0031430); Z disc (GO:0030018); sarcomere (GO:0030017); sarcolemma (GO:0042383). - Cell types (CL): skeletal muscle fiber / myofiber (CL:0000188); fast muscle cell / type II fiber (CL:0000190). - CHEBI: calcium(2+) (CHEBI:29108); creatine (CHEBI:16919); creatinine (CHEBI:16737).
Organ level. Primary: skeletal muscle (striated muscle; UBERON:0001134). Secondary: kidney (UBERON:0002113) via myoglobinuric acute kidney injury. Body system: musculoskeletal/muscular system primarily; renal/urinary system secondarily. The heart (myocardium, UBERON:0002349) is characteristically spared in RHABDO1.
Tissue and cell level. Affected tissue: skeletal muscle tissue (UBERON:0002036); affected cells: skeletal muscle fibers/myofibers (CL:0000188), with type 2 fiber predominance (HP:0010602) on biopsy. Histopathology shows increased fiber-size variability (HP:0003557) and centrally nucleated fibers (HP:0003687).
Subcellular level. Sarcoplasmic reticulum (GO:0016529) — the key disorganized compartment; M-band (GO:0031430) and Z-disk (GO:0030018) where obscurin localizes; sarcolemma (GO:0042383) instability; mitochondria (GO:0005739) secondarily implicated via metabolic/mitophagy changes in models.
Localization / lateralization. Skeletal muscle involvement is generalized/bilateral; imaging in one case showed bilateral lower-limb muscle edema on MRI (PMID: 40186404).
Onset. Typically adolescence (teenage years) per the defining series (PMID: 34957489); additional cases are young adults. Onset of individual episodes is acute, tied to a trigger.
Progression. The disease course is episodic/relapsing rather than steadily progressive. Between episodes, patients are frequently well, though some show distal muscle weakness (HP:0002460) and biopsy changes. Individual rhabdomyolysis episodes evolve acutely (hours), with CK rising rapidly and resolving over days with supportive care.
Patterns. Episodes remit with trigger removal and supportive treatment. The critical window for intervention is during an acute crisis (early aggressive hydration to prevent AKI). Lifelong susceptibility persists; management is about preventing recurrence.
Expressivity. Variable: Sun et al. noted the proband's mother, carrying a homozygous OBSCN variant, had only exercise-induced myalgia, far milder than the proband's rhabdomyolysis — illustrating variable expressivity (PMID: 40186404).
Inheritance pattern. Autosomal recessive — bi-allelic (homozygous or compound-heterozygous) LOF variants required (PMID: 34957489). Supported by gnomAD constraint showing OBSCN tolerates heterozygous LOF (pLI ≈ 0, LOEUF 0.94), so carriers are generally unaffected.
Penetrance / expressivity. Appears trigger-dependent with variable expressivity (e.g., homozygous carrier mother with only myalgia, PMID: 40186404). Penetrance is incompletely defined due to the small number of reported cases.
Epidemiology. Prevalence and incidence are not established — RHABDO1 is a recently defined (2022), rare Mendelian condition with only ~12 reported patients across the literature. No registry-level prevalence/incidence figures exist.
Founder effects / consanguinity / carrier frequency. No founder mutation is established. Consanguinity may facilitate homozygous cases but is not systematically reported. Carrier frequency cannot be reliably estimated but LOF alleles are observed in gnomAD.
Population demographics. No ethnic predilection is established. Cases are reported from multiple populations (including East Asian cases, PMID: 40186404). Sex ratio is not established; reported cases include males and females. Age distribution skews to adolescents/young adults at first presentation.
Laboratory tests. During episodes: markedly elevated serum CK (HP:0003236), myoglobinuria, and renal function monitoring for AKI (HP:0000083). Metabolic workup may show abnormal fatty acylcarnitine profile (HP:0012071) — important because acylcarnitine abnormalities also characterize the key differential (fatty-acid oxidation disorders).
Biomarkers. CK and myoglobin are the principal circulating biomarkers of myofiber breakdown; absent/reduced obscurin on muscle immunostaining/Western blot is a disease-specific tissue marker (PMID: 34957489).
Imaging. Muscle MRI can show muscle edema (bilateral lower-limb edema reported, PMID: 40186404).
Biopsy / histopathology. Muscle biopsy may show increased fiber-size variability (HP:0003557), centrally nucleated fibers (HP:0003687), type 2 fiber predominance (HP:0010602), and reduced/absent obscurin by immunostaining.
Genetic testing (diagnostic cornerstone). Because OBSCN is enormous (121 exons, among the largest human transcripts, PMID: 40025502), next-generation sequencing (WES or WGS) is the practical approach; large multigene rhabdomyolysis/metabolic-myopathy panels that include OBSCN are appropriate. Confirm bi-allelic status and phase (compound-het vs in-cis) with parental testing. Interpret truncating variants as likely causal; treat missense as VUS pending functional/segregation data (PMID: 33438037).
Clinical criteria. No formal consensus diagnostic criteria exist. Working diagnosis = recurrent exertional/metabolic rhabdomyolysis + bi-allelic LOF OBSCN variants + supportive muscle findings (reduced obscurin), after exclusion of commoner causes.
Differential diagnosis. Other genetic rhabdomyolysis susceptibilities and metabolic myopathies must be excluded:
| Differential | Gene / defect | Distinguishing feature |
|---|---|---|
| RYR1-related / malignant hyperthermia susceptibility | RYR1 | Anesthetic-triggered MH; RYR1 variants (PMID: 35285867) |
| VLCAD deficiency (FAO disorder) | ACADVL | Abnormal acylcarnitines; fasting/exercise triggers (PMID: 35405752, PMID: 29153022) |
| McArdle disease (GSD V) | PYGM | Second-wind phenomenon; fixed exercise intolerance (PMID: 41229646) |
| Drug-induced rhabdomyolysis | statins, TKIs | Temporal drug association (PMID: 42473504, PMID: 41585502) |
| Infection-triggered | e.g., SARS-CoV-2 | Acute infection context (PMID: 34871534) |
| Exertional / MH-spectrum | multifactorial | Round-table consensus on ER/EHS/MH overlap (PMID: 28430550) |
Screening. No newborn or population screening exists. Cascade genetic testing of relatives of probands is reasonable for recurrence risk and trigger-avoidance counseling.
Survival / mortality. No disease-specific mortality data. Prognosis is generally good with prompt supportive management; the principal acute risk is myoglobinuric AKI (HP:0000083), which can require dialysis in severe rhabdomyolysis generally (PMID: 33645199). Rhabdomyolysis can occasionally be severe even without electrolyte abnormalities or renal failure (PMID: 42491205).
Morbidity / function. Between episodes, function is often preserved; recurrent crises, hospitalizations, and exercise restriction are the main morbidity. Some patients show distal weakness.
Complications. AKI (sometimes requiring dialysis), electrolyte derangements (hyperkalemia, hyperphosphatemia, hypocalcemia) during severe episodes, and rarely compartment syndrome (general rhabdomyolysis complications).
Recovery potential. Individual episodes typically recover fully with hydration and supportive care; CK normalizes over days.
Prognostic factors. Severity/number of triggers, rapidity of fluid resuscitation, baseline renal function, and degree of CK elevation influence AKI risk. No molecular prognostic biomarker specific to RHABDO1 is established.
No gene-specific therapy exists. Management is supportive and preventive.
Acute episode management. Aggressive intravenous fluid resuscitation to maintain renal perfusion and clear myoglobin; electrolyte correction; renal function monitoring; dialysis if AKI is severe. This mirrors standard rhabdomyolysis care (PMID: 33645199). (NCIT intervention terms: Intravenous Fluid Therapy; Hemodialysis; Supportive Care.)
Preventive / supportive. Trigger avoidance — adequate hydration, avoiding prolonged fasting, graded conditioning rather than sudden intense/unaccustomed exertion, prompt management of febrile illness, and caution with heat. Individualized exercise-tolerance assessment (as applied in metabolic myopathies) may define safe activity limits.
Pharmacotherapy / advanced therapeutics. No approved pharmacologic, gene, cell, or RNA-based therapy is specific to RHABDO1. No pharmacogenomic guidance is established.
Treatment strategy. The practical algorithm: (1) recognize recurrent rhabdomyolysis; (2) rule out common causes; (3) genetic confirmation of bi-allelic OBSCN LOF; (4) acute supportive care during episodes; (5) long-term trigger-avoidance counseling and genetic counseling for the family.
| Model | Type | Key findings | Relevance to RHABDO1 | PMID |
|---|---|---|---|---|
| Obscn / Obsl1 double-KO mouse (skeletal) | Mammalian KO | Only combined deletion reveals roles in sarcolemmal stability and SR organization and muscle metabolism | Strong mechanistic support for SR/sarcolemma defect; highlights OBSL1 redundancy | 31098411 |
| Obscn KO mouse (heart) | Mammalian KO | Reduced SR volume, lower SERCA/PLB, altered Ca²⁺ cycling, compensated dilated cardiomyopathy, arrhythmia | Models the cardiac branch; informs Ca²⁺-handling mechanism | 40366302 |
| Obsc/Obsl1 double-KO (heart) | Mammalian KO | Diastolic dysfunction, perturbed Ca²⁺ cycling, altered metabolism, deregulated mitophagy, ↑UPR | Links obscurin loss to SR + mitochondrial/metabolic dysfunction | 40066567 |
| Obscn-ΔIg58/59 mouse | Knock-in/deletion | Atrial remodeling, Ca²⁺-based arrhythmogenesis, TAT depletion | Domain-specific cardiac model (distinct from skeletal rhabdo) | 39804820 |
| Patient-derived cultured myoblasts | In vitro (human) | Greater decrease in SR Ca²⁺ content upon starvation vs controls | Direct human functional evidence of impaired SR Ca²⁺ handling | 34957489 |
Phenotype recapitulation / limitations. Mouse models robustly recapitulate the SR disorganization and Ca²⁺-handling defect central to RHABDO1, but the cardiac phenotype dominates mouse models whereas human RHABDO1 spares the heart — a key species/isoform discrepancy. No mouse model has been reported that reproduces the human trigger-dependent recurrent skeletal rhabdomyolysis phenotype in isolation, partly because of OBSL1 redundancy. Human patient myoblasts provide the most disease-faithful functional readout to date. Model databases: MGI, IMPC, IMSR for murine resources.
Bi-allelic OBSCN LOF variant (nonsense / frameshift / splice)
│ (demonstrated: reduced OBSCN, absent obscurin in patient muscle)
▼
Loss of obscurin at M-band / Z-disk --X-- (loses titin & myomesin linkage)
│
▼
Disrupted sarcomere->SR coupling -> SR disorganization
+ reduced SERCA / phospholamban (model evidence)
│
▼
Impaired Ca2+ re-uptake & reduced SR Ca2+ storage -> perturbed Ca2+ cycling
│
│<---- TRIGGER (exercise / fasting / fever)
│ (patient myoblasts: lower SR Ca2+ on starvation)
▼
Cytosolic Ca2+ dysregulation + sarcolemmal instability
│
▼
Myofiber necrosis (RHABDOMYOLYSIS)
│
├─> ↑↑ serum CK, myalgia, cramps, exercise intolerance
└─> Myoglobinuria -> Acute kidney injury (risk)
BRANCH (heart): same SR/Ca2+ lesion -> dilated CM / arrhythmia in MICE
but CARDIAC SPARING in human RHABDO1 (isoform/redundancy)
The unifying interpretation: RHABDO1 is a sarcoplasmic-reticulum Ca²⁺-handling disorder of skeletal muscle caused by obscurin loss of function. The upstream lesion is structural (loss of the sarcomere–SR tether); the downstream consequence is a Ca²⁺-buffering deficit that stays clinically silent until a metabolic or mechanical trigger overwhelms the compromised myofiber, producing episodic breakdown. Cardiac sparing in humans — despite a clear cardiac disease axis in mice and in OBSCN-cardiomyopathy literature — is the most striking unexplained feature and points to tissue-specific isoform usage and OBSL1 redundancy.
| PMID | Study | Role in this report |
|---|---|---|
| 34957489 | Cabrera-Serrano et al., Brain 2022 — defining case series | Primary source: 10 bi-allelic LOF OBSCN variants in 6 patients; reduced OBSCN/absent obscurin; starvation-sensitive SR Ca²⁺ in myoblasts; cardiac sparing; teenage onset |
| 38159459 | Zemorshidi 2024 — case report | Two young patients, novel variants, exercise intolerance/rhabdomyolysis without cardiomyopathy |
| 40186404 | Sun 2025 — case report | Compound-het nonsense+splice; homozygous mother with milder phenotype (variable expressivity); MRI muscle edema, no cardiac abnormality |
| 40813169 | Liu 2025 — case report + review | Young adult, two OBSCN variants; reinforces pathogenic role; notes mechanism unclear |
| 31098411 | Murine Obscn/Obsl1 — skeletal | Only combined deletion reveals SR organization + sarcolemmal stability roles (mechanism) |
| 40366302 | Obscn KO heart | Reduced SR volume, ↓SERCA/PLB, altered Ca²⁺ cycling (mechanism; cardiac branch) |
| 40066567 | Obsc/Obsl1 KO heart | SR + mitochondrial/metabolic dysfunction, mitophagy (mechanism) |
| 39804820 | Obscn-ΔIg58/59 | Atrial Ca²⁺ arrhythmogenesis (distinct cardiac axis) |
| 18477606 | Titin/myomesin–obscurin M-band | Molecular basis of obscurin M-band targeting |
| 20133654 | Titin M10–obsl1 structure | M-band complex structure; disease mutations disrupt it |
| 11448995 | Obscurin discovery | ~800 kDa, 1q42, IQ + RhoGEF signaling, titin binding |
| 19605563 | Obscurin RhoGEF | Activates RhoA at M-band; injury response |
| 33438037 | Obscurin missense variants | Cautionary: R4344Q/R4444W not clearly pathogenic; supports VUS treatment of missense |
| 40025502 | OBSCN splicing | 121 exons; extensive alternative splicing; cardiac vs skeletal isoforms |
| 39880734 | Equine exertional rhabdomyolysis | Comparative biology context |
| 33645199 | Rhabdomyolysis→AKI | Supportive-care/complication context |
Report compiled from the OBSCN/RHABDO1 primary literature, gnomAD v2.1.1 constraint data, ClinVar (NM_001386125.1), UniProt Q5VST9, and Monarch/HPO disease–phenotype annotations for MONDO:0859371. Evidence types are indicated throughout as human clinical, model organism, in vitro, or computational.
Checked with linkml-reference-validator 0.4.0.
| Outcome | Count |
|---|---|
| References checked | 25 |
| Resolved | 25 |
| Unresolved (possible confabulation) | 0 |
| Unverifiable | 0 |
| Quoted claims checked | 3 |
| Quoted claims found in source | 3 |
| Quoted claims not found in source | 0 |
| References weighed for topical relevance | 25 |
| On topic | 11 |
| Off topic | 0 |
All extracted references resolved successfully.
Checked with linkml-term-validator 0.4.5, through the ols: adapter.
| Outcome | Count |
|---|---|
| Terms checked | 32 |
| Resolved | 31 |
| Unresolved (possible confabulation) | 0 |
| Obsolete | 0 |
| Unverifiable | 1 |
| Terms whose name was checked | 19 |
| Terms named correctly | 9 |
| Terms named as a different term | 2 |
| Terms whose name is worth a second look | 8 |
These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:
MONDO:0859371 (4 mentions) - the report calls it "MONDO"; MONDO calls it rhabdomyolysis, susceptibility to, 1HP:0000083 (3 mentions) - the report calls it "Renal insufficiency", "myoglobinuric AKI"; HP calls it Renal insufficiencyThe report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:
HP:0003236 (2 mentions) - the report calls it "Elevated circulating creatine kinase", "markedly elevated serum CK"; HP calls it Elevated circulating creatine kinase activity, and lists "Elevated serum CPK" among its other namesHP:0010602 (3 mentions) - the report calls it "Type 2 muscle fiber predominance", "type 2 fiber predominance"; HP calls it Type 2 muscle fiber predominanceHP:0012071 (4 mentions) - the report calls it "Abnormal circulating fatty acylcarnitine concentration", "abnormal fatty acylcarnitine profile"; HP calls it Abnormal circulating fatty acylcarnitine concentration, and lists "Abnormal fatty acylcarnitine level" among its other namesGO:0016529 (2 mentions) - the report calls it "GO cellular component: sarcoplasmic reticulum", "Sarcoplasmic reticulum"; GO calls it sarcoplasmic reticulum**GO:0030018 (2 mentions) - the report calls it "Z-disk"; GO calls it Z disc, and lists "Z disk" among its other namesCL:0000188 (2 mentions) - the report calls it "skeletal muscle fibers/myofibers"; CL calls it cell of skeletal muscle, and lists "skeletal muscle cell" among its other namesUBERON:0002036 (1 mention) - the report calls it "skeletal muscle tissue"; UBERON calls it striated muscle tissueGO:0005739 (1 mention) - the report calls it "mitochondria"; GO calls it mitochondrion, and lists "mitochondria" among its other namesThe report gives these identifiers more than one name of its own:
HP:0003236 - called "Elevated circulating creatine kinase", "markedly elevated serum CK"HP:0000083 - called "Renal insufficiency", "myoglobinuric AKI"HP:0010602 - called "Type 2 muscle fiber predominance", "type 2 fiber predominance"HP:0002460 - called "Distal muscle weakness", "distal muscle weakness"HP:0012071 - called "Abnormal circulating fatty acylcarnitine concentration", "abnormal fatty acylcarnitine profile"GO:0016529 - called "GO cellular component:** sarcoplasmic reticulum", "Sarcoplasmic reticulum"